154 related articles for article (PubMed ID: 36419348)
21. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
[TBL] [Abstract][Full Text] [Related]
22. Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy.
Lehman A; Thouta S; Mancini GMS; Naidu S; van Slegtenhorst M; McWalter K; Person R; Mwenifumbo J; Salvarinova R; ; ; Guella I; McKenzie MB; Datta A; Connolly MB; Kalkhoran SM; Poburko D; Friedman JM; Farrer MJ; Demos M; Desai S; Claydon T
Am J Hum Genet; 2017 Jul; 101(1):65-74. PubMed ID: 28669405
[TBL] [Abstract][Full Text] [Related]
23. A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy.
Rydzanicz M; Zwoliński P; Gasperowicz P; Pollak A; Kostrzewa G; Walczak A; Konarzewska M; Płoski R
Am J Med Genet A; 2021 Nov; 185(11):3384-3389. PubMed ID: 34448338
[TBL] [Abstract][Full Text] [Related]
24. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
[No Abstract] [Full Text] [Related]
25. Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies.
Krüger J; Schubert J; Kegele J; Labalme A; Mao M; Heighway J; Seebohm G; Yan P; Koko M; Aslan-Kara K; Caglayan H; Steinhoff BJ; Weber YG; Keo-Kosal P; Berkovic SF; Hildebrand MS; Petrou S; Krause R; May P; Lesca G; Maljevic S; Lerche H
EBioMedicine; 2022 Oct; 84():104244. PubMed ID: 36088682
[TBL] [Abstract][Full Text] [Related]
26. Functional effects of spinocerebellar ataxia type 13 mutations are conserved in zebrafish Kv3.3 channels.
Mock AF; Richardson JL; Hsieh JY; Rinetti G; Papazian DM
BMC Neurosci; 2010 Aug; 11():99. PubMed ID: 20712895
[TBL] [Abstract][Full Text] [Related]
27. Utilising Automated Electrophysiological Platforms in Epilepsy Research.
Milligan CJ; Pachernegg S
Methods Mol Biol; 2021; 2188():133-155. PubMed ID: 33119850
[TBL] [Abstract][Full Text] [Related]
28. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.
Waters MF; Minassian NA; Stevanin G; Figueroa KP; Bannister JP; Nolte D; Mock AF; Evidente VG; Fee DB; Müller U; Dürr A; Brice A; Papazian DM; Pulst SM
Nat Genet; 2006 Apr; 38(4):447-51. PubMed ID: 16501573
[TBL] [Abstract][Full Text] [Related]
29. Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang-Wang syndrome.
Liang L; Liu H; Bartholdi D; van Haeringen A; Fernandez-Jaén A; Peeters EEA; Xiong H; Bai X; Xu C; Ke T; Wang QK
Acta Physiol (Oxf); 2022 May; 235(1):e13800. PubMed ID: 35156297
[TBL] [Abstract][Full Text] [Related]
30. SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation.
Zaman T; Helbig KL; Clatot J; Thompson CH; Kang SK; Stouffs K; Jansen AE; Verstraete L; Jacquinet A; Parrini E; Guerrini R; Fujiwara Y; Miyatake S; Ben-Zeev B; Bassan H; Reish O; Marom D; Hauser N; Vu TA; Ackermann S; Spencer CE; Lippa N; Srinivasan S; Charzewska A; Hoffman-Zacharska D; Fitzpatrick D; Harrison V; Vasudevan P; Joss S; Pilz DT; Fawcett KA; Helbig I; Matsumoto N; Kearney JA; Fry AE; Goldberg EM
Ann Neurol; 2020 Aug; 88(2):348-362. PubMed ID: 32515017
[TBL] [Abstract][Full Text] [Related]
31. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
[TBL] [Abstract][Full Text] [Related]
32. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
[TBL] [Abstract][Full Text] [Related]
33. Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1.
Hurlock EC; Bose M; Pierce G; Joho RH
J Neurosci; 2009 Dec; 29(50):15735-44. PubMed ID: 20016089
[TBL] [Abstract][Full Text] [Related]
34. Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.
Lau D; Vega-Saenz de Miera EC; Contreras D; Ozaita A; Harvey M; Chow A; Noebels JL; Paylor R; Morgan JI; Leonard CS; Rudy B
J Neurosci; 2000 Dec; 20(24):9071-85. PubMed ID: 11124984
[TBL] [Abstract][Full Text] [Related]
35. K
Boddum K; Hougaard C; Xiao-Ying Lin J; von Schoubye NL; Jensen HS; Grunnet M; Jespersen T
Neuropharmacology; 2017 May; 118():102-112. PubMed ID: 28242439
[TBL] [Abstract][Full Text] [Related]
36. Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia type 13.
Minassian NA; Lin MC; Papazian DM
J Physiol; 2012 Apr; 590(7):1599-614. PubMed ID: 22289912
[TBL] [Abstract][Full Text] [Related]
37. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
[TBL] [Abstract][Full Text] [Related]
38. Cryo-EM structure of the human Kv3.1 channel reveals gating control by the cytoplasmic T1 domain.
Chi G; Liang Q; Sridhar A; Cowgill JB; Sader K; Radjainia M; Qian P; Castro-Hartmann P; Venkaya S; Singh NK; McKinley G; Fernandez-Cid A; Mukhopadhyay SMM; Burgess-Brown NA; Delemotte L; Covarrubias M; Dürr KL
Nat Commun; 2022 Jul; 13(1):4087. PubMed ID: 35840580
[TBL] [Abstract][Full Text] [Related]
39. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
40. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
